The true strength of Shockwave Medical is a remarkable team of talented individuals with decades of experience in the medical device industry. Passionate, ethical, and focused, we are dedicated to developing technologies that enable interventionalist to raise the standard of how advanced cardiovascular disease is treated.
If this sounds like something you would want to be part of, consider working with us.
President & Chief Executive Officer
Doug Godshall was most recently the Chief Executive Officer and a director of HeartWare International, Inc., a leader in the LVAD market where he served for 10 years until the company was acquired by Medtronic in August of 2016 for $1.1B. Prior to HeartWare, he held various executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, a member of Boston Scientific’s Operating Committee and had previously served as Vice President, Business Development where he was responsible for more than 70 transactions, many of which were in the arenas of coronary and peripheral interventions. Mr. Godshall holds an M.B.A. from Northeastern University and a BA in Economics from Lafayette College.
Rob Williamson, Jr.
VP of Sales
Prior to joining Shockwave, Rob spent the majority of his 20 year device career in the vascular space. Most recently, Rob served in a Sales Director position for Zoll in their Cardiac Management Solutions division, and prior to that, Rob served as a Director and Vice President with Medtronic (formerly Covidien) in their Peripheral Vascular division. He has also served in sales and sales leadership positions with C.R. Bard, FoxHollow and ev3. Rob holds a B.A. from Auburn University.
Chief Financial Officer
Prior to Shockwave Medical, Mr. Puckett served as Chief Financial Officer for Counsyl, a venture backed DNA testing and genetic counseling company. From 2011 to 2015 he served as Chief Financial Officer for Ariosa Diagnostics, a molecular diagnostics company (acquired by Roche in 2015). Mr. Puckett came to Ariosa from Forest Laboratories where he served as Executive Director, Operations of Cerexa, a Forest Laboratories subsidiary. While at Cerexa, Mr. Puckett was part of the leadership team that was responsible for obtaining FDA approval for the drug Teflaro. Prior to Cerexa, he held senior finance and operations positions at Affymetrix, AOL, Viad, and BHP Billiton. Mr. Puckett holds an M.B.A. from the University of San Francisco and a B.A. degree in Accounting from Washington State University.
VP of Clinical Affairs
Prior to Shockwave Medical, Beaux served as Senior Director of Clinical Research at Medtronic’s Aortic and Peripheral Vascular business unit. During his 12 year tenure, he led clinical programs which introduced multiple aortic stent graft platforms into the U.S. and Japanese markets. Most recently, he was responsible for the global peripheral program, which included the successful launch of drug-coated balloons in the U.S., along with global expansion in additional geographies. Beaux holds a B.S. in Allied Health from Ohio State University and an M.B.A. from Georgia State University.
VP of Marketing
Rob joined Shockwave Medical from Medtronic where he was Chief Commercial Officer and then Managing Director for a startup joint venture whose aim was to expand access to modern acute cardiovascular care in a major emerging market through a public private partnership, a flagship strategic alliance for the company. Prior to that he was Senior Director of Global Marketing, leading the marketing function in Medtronic’s interventional cardiology franchise through a period of 30% growth to $1.8B in revenue. Rob has over 18-years of experience in interventional cardiology, holding positions in marketing, sales, business development and R&D. He holds a B.S. in Chemical Engineering from the University of Florida and M.B.A. from the Kellogg School of Management at Northwestern University.
GM of Structural Heart, VP of International Sales
Mr. Zacharias has over 20 years of experience in the medical device industry. Prior to joining Shockwave Medical, Mr. Zacharias served as the Vice President, General Manager for the PCI Guidance business at Boston Scientific, where he led a turnaround of this franchise resulting in 15 consecutive quarters of revenue growth, share gain, and operating income leverage. Prior to that, Mr. Zacharias served as the Vice President, New Business Development for Boston Scientific where he negotiated investments and acquisitions totaling more than $1 billion for the Cardiology, Rhythm Management, and Vascular business units. Mr. Zacharias began his career as an R&D engineer and has held a variety of clinical and marketing roles. Mr. Zacharias holds B.S. and M.S. degrees in Mechanical Engineering from the University of California, Davis.
VP of Research & Development
Patrick Stephens joined us in August 2018 from Endologix where he was Vice President, Research and Development. Prior to Endologix, Mr. Stephens served in various roles of increasing responsibility at Trivascular, including most recently Vice President, Product Development. Mr. Stephens has more than 25 years of experience in the design, development and manufacturing of medical devices and previously served in roles at Medtronic, Boston Scientific and W.L. Gore. Mr. Stephens received his M.S. in Mechanical Engineering from the University of Arizona and his B.S. in Mechanical Engineering from the University of Colorado.